• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2023 Jan 24;120(4):e2208425120.
doi: 10.1073/pnas.2208425120. Epub 2023 Jan 20.
Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge


Dan Bi Lee[SUP] 1 [/SUP], Hyojin Kim[SUP] 2 [/SUP], Ju Hwan Jeong[SUP] 3 [/SUP], Ui Soon Jang[SUP] 1 4 [/SUP], Yuyeon Jang[SUP] 1 4 [/SUP], Seokbeom Roh[SUP] 1 4 [/SUP], Hyunbum Jeon[SUP] 5 [/SUP], Eun Jeong Kim[SUP] 1 [/SUP], Su Yeon Han[SUP] 1 [/SUP], Jin Young Maeng[SUP] 2 [/SUP], Stefan Magez[SUP] 6 7 8 [/SUP], Magdalena Radwanska[SUP] 6 9 [/SUP], Ji Young Mun[SUP] 10 [/SUP], Hyun Sik Jun[SUP] 1 4 [/SUP], Gyudo Lee[SUP] 1 4 [/SUP], Min-Suk Song[SUP] 3 [/SUP], Hye-Ra Lee[SUP] 1 4 [/SUP], Mi Sook Chung[SUP] 2 [/SUP], Yun Hee Baek[SUP] 3 [/SUP], Kyung Hyun Kim[SUP] 1 [/SUP]



Affiliations

Abstract

Recurrent spillovers of α- and β-coronaviruses (CoV) such as severe acute respiratory syndrome (SARS)-CoV, Middle East respiratory syndrome-CoV, SARS-CoV-2, and possibly human CoV have caused serious morbidity and mortality worldwide. In this study, six receptor-binding domains (RBDs) derived from α- and β-CoV that are considered to have originated from animals and cross-infected humans were linked to a heterotrimeric scaffold, proliferating cell nuclear antigen (PCNA) subunits, PCNA1, PCNA2, and PCNA3. They assemble to create a stable mosaic multivalent nanoparticle, 6RBD-np, displaying a ring-shaped disk with six protruding antigens, like jewels in a crown. Prime-boost immunizations with 6RBD-np in mice induced significantly high Ab titers against RBD antigens derived from α- and β-CoV and increased interferon (IFN-γ) production, with full protection against the SARS-CoV-2 wild type and Delta challenges. The mosaic 6RBD-np has the potential to induce intergenus cross-reactivity and to be developed as a pan-CoV vaccine against future CoV spillovers.

Keywords: SARS-CoV-2; immune response; mosaic multivalent antigens; receptor-binding domain; spike.
 
Back
Top Bottom